Matches in SemOpenAlex for { <https://semopenalex.org/work/W3134263637> ?p ?o ?g. }
- W3134263637 endingPage "1981" @default.
- W3134263637 startingPage "1970" @default.
- W3134263637 abstract "Epigenetic regulators are a class of promising targets in combination with immune checkpoint inhibitors for cancer treatment, but the impact of the broad effects of perturbing epigenetic regulators on tumor immunotherapy remains to be fully explored. Here we show that ablation of the histone demethylase LSD1 in multiple tumor cells induces TGFβ expression, which exerts an inhibitory effect on T-cell immunity through suppressing the cytotoxicity of intratumoral CD8+ T cells and consequently dampens the antitumor effect of LSD1 ablation-induced T-cell infiltration. Importantly, concurrent depletion of LSD1 and TGFβ in combination with PD-1 blockade significantly increases both CD8+ T-cell infiltration and cytotoxicity, leading to eradication of poorly immunogenic tumors and a long-term protection from tumor rechallenge. Thus, combining LSD1 inhibition with blockade of TGFβ and PD-1 may represent a promising triple combination therapy for treating certain refractory tumors. SIGNIFICANCE: Cotargeting LSD1 and TGFβ cooperatively elevates intratumoral CD8+ T-cell infiltration and unleashes their cytotoxicity, leading to tumor eradication upon anti-PD-1 treatment. Our findings illustrate a duality of epigenetic perturbations in immunotherapy and implicate the combination of LSD1 inhibition with dual PD-1/TGFβ blockade in treating certain poorly immunogenic tumors.This article is highlighted in the In This Issue feature, p. 1861." @default.
- W3134263637 created "2021-03-15" @default.
- W3134263637 creator A5008659449 @default.
- W3134263637 creator A5013379959 @default.
- W3134263637 creator A5051695126 @default.
- W3134263637 creator A5069136549 @default.
- W3134263637 creator A5075344045 @default.
- W3134263637 date "2021-03-09" @default.
- W3134263637 modified "2023-10-14" @default.
- W3134263637 title "Simultaneous Inhibition of LSD1 and TGFβ Enables Eradication of Poorly Immunogenic Tumors with Anti–PD-1 Treatment" @default.
- W3134263637 cites W1905278501 @default.
- W3134263637 cites W1953890763 @default.
- W3134263637 cites W2003325719 @default.
- W3134263637 cites W2034156554 @default.
- W3134263637 cites W2039347592 @default.
- W3134263637 cites W2045963664 @default.
- W3134263637 cites W2062929087 @default.
- W3134263637 cites W2074604431 @default.
- W3134263637 cites W2074632761 @default.
- W3134263637 cites W2103021272 @default.
- W3134263637 cites W2109023646 @default.
- W3134263637 cites W2135596200 @default.
- W3134263637 cites W2156106286 @default.
- W3134263637 cites W2163240418 @default.
- W3134263637 cites W2578528809 @default.
- W3134263637 cites W2587048937 @default.
- W3134263637 cites W2602612283 @default.
- W3134263637 cites W2621717521 @default.
- W3134263637 cites W2782124401 @default.
- W3134263637 cites W2783370150 @default.
- W3134263637 cites W2785803176 @default.
- W3134263637 cites W2788975052 @default.
- W3134263637 cites W2791483720 @default.
- W3134263637 cites W2802645166 @default.
- W3134263637 cites W2809237949 @default.
- W3134263637 cites W2883220169 @default.
- W3134263637 cites W2912552280 @default.
- W3134263637 cites W2913744515 @default.
- W3134263637 cites W2919408146 @default.
- W3134263637 cites W2931391344 @default.
- W3134263637 cites W2937823726 @default.
- W3134263637 cites W2970548174 @default.
- W3134263637 cites W3044762644 @default.
- W3134263637 doi "https://doi.org/10.1158/2159-8290.cd-20-0017" @default.
- W3134263637 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8598400" @default.
- W3134263637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33687985" @default.
- W3134263637 hasPublicationYear "2021" @default.
- W3134263637 type Work @default.
- W3134263637 sameAs 3134263637 @default.
- W3134263637 citedByCount "29" @default.
- W3134263637 countsByYear W31342636372021 @default.
- W3134263637 countsByYear W31342636372022 @default.
- W3134263637 countsByYear W31342636372023 @default.
- W3134263637 crossrefType "journal-article" @default.
- W3134263637 hasAuthorship W3134263637A5008659449 @default.
- W3134263637 hasAuthorship W3134263637A5013379959 @default.
- W3134263637 hasAuthorship W3134263637A5051695126 @default.
- W3134263637 hasAuthorship W3134263637A5069136549 @default.
- W3134263637 hasAuthorship W3134263637A5075344045 @default.
- W3134263637 hasBestOaLocation W31342636371 @default.
- W3134263637 hasConcept C109316439 @default.
- W3134263637 hasConcept C154317977 @default.
- W3134263637 hasConcept C167672396 @default.
- W3134263637 hasConcept C170493617 @default.
- W3134263637 hasConcept C202751555 @default.
- W3134263637 hasConcept C203014093 @default.
- W3134263637 hasConcept C2776090121 @default.
- W3134263637 hasConcept C2777701055 @default.
- W3134263637 hasConcept C2777877232 @default.
- W3134263637 hasConcept C2778468042 @default.
- W3134263637 hasConcept C2780674031 @default.
- W3134263637 hasConcept C2780851360 @default.
- W3134263637 hasConcept C502942594 @default.
- W3134263637 hasConcept C55493867 @default.
- W3134263637 hasConcept C86803240 @default.
- W3134263637 hasConcept C8891405 @default.
- W3134263637 hasConceptScore W3134263637C109316439 @default.
- W3134263637 hasConceptScore W3134263637C154317977 @default.
- W3134263637 hasConceptScore W3134263637C167672396 @default.
- W3134263637 hasConceptScore W3134263637C170493617 @default.
- W3134263637 hasConceptScore W3134263637C202751555 @default.
- W3134263637 hasConceptScore W3134263637C203014093 @default.
- W3134263637 hasConceptScore W3134263637C2776090121 @default.
- W3134263637 hasConceptScore W3134263637C2777701055 @default.
- W3134263637 hasConceptScore W3134263637C2777877232 @default.
- W3134263637 hasConceptScore W3134263637C2778468042 @default.
- W3134263637 hasConceptScore W3134263637C2780674031 @default.
- W3134263637 hasConceptScore W3134263637C2780851360 @default.
- W3134263637 hasConceptScore W3134263637C502942594 @default.
- W3134263637 hasConceptScore W3134263637C55493867 @default.
- W3134263637 hasConceptScore W3134263637C86803240 @default.
- W3134263637 hasConceptScore W3134263637C8891405 @default.
- W3134263637 hasFunder F4320332161 @default.
- W3134263637 hasIssue "8" @default.
- W3134263637 hasLocation W31342636371 @default.
- W3134263637 hasLocation W313426363710 @default.
- W3134263637 hasLocation W31342636372 @default.
- W3134263637 hasLocation W31342636373 @default.